{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:15:12Z","timestamp":1788822912800,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,7,7]],"date-time":"2014-07-07T00:00:00Z","timestamp":1404691200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1038\/aps.2014.45","type":"journal-article","created":{"date-parts":[[2014,7,7]],"date-time":"2014-07-07T09:01:48Z","timestamp":1404723708000},"page":"1005-1014","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Aliskiren ameliorates pressure overload-induced heart hypertrophy and fibrosis in mice"],"prefix":"10.1038","volume":"35","author":[{"given":"Li-qing","family":"Weng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-pei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha-sha","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-yun","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-bo","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-zeng","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,7]]},"reference":[{"key":"BFaps201445_CR1","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1056\/NEJM199210013271406","volume":"327","author":"ED Frohlich","year":"1992","unstructured":"Frohlich ED, Apstein C, Chobanian AV, Devereux RB, Dustan HP, Dzau V, et al. The heart in hypertension. N Engl J Med 1992; 327: 998\u20131008.","journal-title":"N Engl J Med"},{"key":"BFaps201445_CR2","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","volume":"359","author":"B Dahlof","year":"2002","unstructured":"Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359: 995\u20131003.","journal-title":"Lancet"},{"key":"BFaps201445_CR3","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/eurheartj\/ehm605","volume":"29","author":"G de Simone","year":"2008","unstructured":"de Simone G, Gottdiener JS, Chinali M, Maurer MS . Left ventricular mass predicts heart failure not related to previous myocardial infarction: the Cardiovascular Health Study. Eur Heart J 2008; 29: 741\u20137.","journal-title":"Eur Heart J"},{"key":"BFaps201445_CR4","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1161\/CIR.0b013e318245fac5","volume":"125","author":"VL Roger","year":"2012","unstructured":"Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics \u2014 2012 update: a report from the American Heart Association. Circulation 2012; 125: e2\u2013e220.","journal-title":"Circulation"},{"key":"BFaps201445_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","volume":"65","author":"N Frey","year":"2003","unstructured":"Frey N, Olson EN . Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 2003; 65: 45\u201379.","journal-title":"Annu Rev Physiol"},{"key":"BFaps201445_CR6","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1001\/jama.288.12.1491","volume":"288","author":"SE Kjeldsen","year":"2002","unstructured":"Kjeldsen SE, Dahlof B, Devereux RB, Julius S, Aurup P, Edelman J, et al. Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy. JAMA 2002; 288: 1491\u20138.","journal-title":"JAMA"},{"key":"BFaps201445_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/nrcardio.2012.196","volume":"10","author":"CC Lang","year":"2013","unstructured":"Lang CC, Struthers AD . Targeting the renin-angiotensin-aldosterone system in heart failure. Nat Rev Cardiol 2013; 10: 125\u201334.","journal-title":"Nat Rev Cardiol"},{"key":"BFaps201445_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10557-010-6278-0","volume":"25","author":"HM Siragy","year":"2011","unstructured":"Siragy HM . Rationale for combining a direct renin inhibitor with other renin-angiotensin system blockers. Focus on aliskiren and combinations. Cardiovasc Drugs Ther 2011; 25: 87\u201397.","journal-title":"Cardiovasc Drugs Ther"},{"key":"BFaps201445_CR9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/eurjhf\/hfr125","volume":"14","author":"AM Shah","year":"2012","unstructured":"Shah AM, Shin SH, Takeuchi M, Skali H, Desai AS, Kober L, et al. Left ventricular systolic and diastolic function, remodelling, and clinical outcomes among patients with diabetes following myocardial infarction and the influence of direct renin inhibition with aliskiren. Eur J Heart Failure 2012; 14: 185\u201392.","journal-title":"Eur J Heart Failure"},{"key":"BFaps201445_CR10","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1136\/bmj.e42","volume":"344","author":"Z Harel","year":"2012","unstructured":"Harel Z, Gilbert C, Wald R, Bell C, Perl J, Juurlink D, et al. The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: systematic review and meta-analysis. BMJ 2012; 344: e42.","journal-title":"BMJ"},{"key":"BFaps201445_CR11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.2174\/157488612800492771","volume":"7","author":"F Angeli","year":"2012","unstructured":"Angeli F, Reboldi G, Mazzotta G, Poltronieri C, Garofoli M, Ramundo E, et al. Safety and efficacy of aliskiren in the treatment of hypertension and associated clinical conditions. Curr Drug Saf 2012; 7: 76\u201385.","journal-title":"Curr Drug Saf"},{"key":"BFaps201445_CR12","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1172\/JCI27523","volume":"117","author":"H Zhu","year":"2007","unstructured":"Zhu H, Tannous P, Johnstone JL, Kong Y, Shelton JM, Richardson JA, et al. Cardiac autophagy is a maladaptive response to hemodynamic stress. J Clin Invest 2007; 117: 1782\u201393.","journal-title":"J Clin Invest"},{"key":"BFaps201445_CR13","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1161\/CIRCRESAHA.108.186551","volume":"103","author":"BA Rothermel","year":"2008","unstructured":"Rothermel BA, Hill JA . Autophagy in load-induced heart disease. Circ Res 2008; 103: 1363\u20139.","journal-title":"Circ Res"},{"key":"BFaps201445_CR14","first-page":"130","volume":"27","author":"SF Steinberg","year":"2012","unstructured":"Steinberg SF . Cardiac actions of protein kinase C isoforms. Physiology (Bethesda) 2012; 27: 130\u20139.","journal-title":"Physiology (Bethesda)"},{"key":"BFaps201445_CR15","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.yjmcc.2010.10.004","volume":"51","author":"Q Liu","year":"2011","unstructured":"Liu Q, Molkentin JD . Protein kinase Calpha as a heart failure therapeutic target. J Mol Cell Cardiol 2011; 51: 474\u20138.","journal-title":"J Mol Cell Cardiol"},{"key":"BFaps201445_CR16","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1161\/CIRCULATIONAHA.105.592550","volume":"114","author":"M Hambleton","year":"2006","unstructured":"Hambleton M, Hahn H, Pleger ST, Kuhn MC, Klevitsky R, Carr AN, et al. Pharmacological- and gene therapy-based inhibition of protein kinase Calpha\/beta enhances cardiac contractility and attenuates heart failure. Circulation 2006; 114: 574\u201382.","journal-title":"Circulation"},{"key":"BFaps201445_CR17","doi-asserted-by":"publisher","first-page":"H2264","DOI":"10.1152\/ajpheart.2001.280.5.H2264","volume":"280","author":"BB Roman","year":"2001","unstructured":"Roman BB, Geenen DL, Leitges M, Buttrick PM . PKC-beta is not necessary for cardiac hypertrophy. Am J Physiol Heart Circ Physiol 2001; 280: H2264\u201370.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFaps201445_CR18","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/ncb1137","volume":"6","author":"Y Zou","year":"2004","unstructured":"Zou Y, Akazawa H, Qin Y, Sano M, Takano H, Minamino T, et al. Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II. Nat Cell Biol 2004; 6: 499\u2013506.","journal-title":"Nat Cell Biol"},{"key":"BFaps201445_CR19","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/nature05602","volume":"446","author":"M Sano","year":"2007","unstructured":"Sano M, Minamino T, Toko H, Miyauchi H, Orimo M, Qin Y, et al. p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 2007; 446: 444\u20138.","journal-title":"Nature"},{"key":"BFaps201445_CR20","doi-asserted-by":"publisher","first-page":"H2797","DOI":"10.1152\/ajpheart.2000.279.6.H2797","volume":"279","author":"WS Akers","year":"2000","unstructured":"Akers WS, Cross A, Speth R, Dwoskin LP, Cassis LA . Renin-angiotensin system and sympathetic nervous system in cardiac pressure-overload hypertrophy. Am J Physiol Heart Circ Physiol 2000; 279: H2797\u2013806.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFaps201445_CR21","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1111\/j.1582-4934.2012.01536.x","volume":"16","author":"WB Zhang","year":"2012","unstructured":"Zhang WB, Du QJ, Li H, Sun AJ, Qiu ZH, Wu CN, et al. The therapeutic effect of rosuvastatin on cardiac remodelling from hypertrophy to fibrosis during the end-stage hypertension in rats. J Cell Mol Med 2012; 16: 2227\u201337.","journal-title":"J Cell Mol Med"},{"key":"BFaps201445_CR22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/jmcb\/mjs055","volume":"5","author":"X Xu","year":"2013","unstructured":"Xu X, Hua Y, Nair S, Zhang Y, Ren J . Akt2 knockout preserves cardiac function in high-fat diet-induced obesity by rescuing cardiac autophagosome maturation. J Mol Cell Biol 2013; 5: 61\u20133.","journal-title":"J Mol Cell Biol"},{"key":"BFaps201445_CR23","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1161\/01.CIR.0000130641.08705.45","volume":"109","author":"JR McMullen","year":"2004","unstructured":"McMullen JR, Sherwood MC, Tarnavski O, Zhang L, Dorfman AL, Shioi T, et al. Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload. Circulation 2004; 109: 3050\u20135.","journal-title":"Circulation"},{"key":"BFaps201445_CR24","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1161\/HYPERTENSIONAHA.113.02219","volume":"63","author":"X Xu","year":"2014","unstructured":"Xu X, Hua Y, Nair S, Bucala R, Ren J . Macrophage migration inhibitory factor deletion exacerbates pressure overload-induced cardiac hypertrophy through mitigating autophagy. Hypertension 2014; 63: 490\u20139.","journal-title":"Hypertension"},{"key":"BFaps201445_CR25","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1073\/pnas.1015081108","volume":"108","author":"DJ Cao","year":"2011","unstructured":"Cao DJ, Wang ZV, Battiprolu PK, Jiang N, Morales CR, Kong Y, et al. Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy. Proc Natl Acad Sci U S A 2011; 108: 4123\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFaps201445_CR26","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.yjmcc.2011.06.010","volume":"51","author":"A Nemchenko","year":"2011","unstructured":"Nemchenko A, Chiong M, Turer A, Lavandero S, Hill JA . Autophagy as a therapeutic target in cardiovascular disease. J Mol Cell Cardiol 2011; 51: 584\u201393.","journal-title":"J Mol Cell Cardiol"},{"key":"BFaps201445_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11010-007-9533-3","volume":"305","author":"G Simonis","year":"2007","unstructured":"Simonis G, Briem SK, Schoen SP, Bock M, Marquetant R, Strasser RH . Protein kinase C in the human heart: differential regulation of the isoforms in aortic stenosis or dilated cardiomyopathy. Mol Cell Biochem 2007; 305: 103\u201311.","journal-title":"Mol Cell Biochem"},{"key":"BFaps201445_CR28","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm1000","volume":"10","author":"JC Braz","year":"2004","unstructured":"Braz JC, Gregory K, Pathak A, Zhao W, Sahin B, Klevitsky R, et al. PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nat Med 2004; 10: 248\u201354.","journal-title":"Nat Med"},{"key":"BFaps201445_CR29","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1440-1681.2011.05572.x","volume":"38","author":"DJ Campbell","year":"2011","unstructured":"Campbell DJ, Zhang Y, Kelly DJ, Gilbert RE, McCarthy DJ, Shi W, et al. Aliskiren increases bradykinin and tissue kallikrein mRNA levels in the heart. Clin Exp Pharmacol Physiol 2011; 38: 623\u201331.","journal-title":"Clin Exp Pharmacol Physiol"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/aps201445.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps201445","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps201445.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:31:33Z","timestamp":1684413093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/aps201445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,7]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["BFaps201445"],"URL":"https:\/\/doi.org\/10.1038\/aps.2014.45","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,7]]},"assertion":[{"value":"9 December 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}